Libre Duo devices become the first glucose-ketone monitors approved for diabetes care, offering real-time alerts for diabetic ketoacidosis risk
The move marks one of the most significant coverage expansions yet in obesity care, bringing FDA-approved treatment options further into mainstream insurance plans rather than out-of-pocket reach
The Establishment Inspection Report came following closure of a product- specific pre-approval inspection from March 2 to March 7, 2026
A one-shot gene-editing cholesterol therapy could soon be a reality
The company said all doses achieved statistically significant reductions in body weight compared with placebo at 72 weeks
Veteran consumer health and FMCG strategist to lead preventive wellness and nutrition portfolio expansion through innovation and modern trade channels
SFDA nod marks company’s strategic entry into high-value specialty oncology injectables as it targets expanding stem cell transplant and haemato-oncology market in the GCC region
Approved product is therapeutically equivalent to Synthroid of AbbVie and is indicated for the treatment of congenital or acquired hypothyroidism
By leveraging digital screening and remote consultation, the medical community is moving beyond the confines of the clinic
The drug is indicated for the maintenance treatment of patients with Chronic Obstructive Pulmonary Disease (COPD)
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
